Drugs for ailments like malaria and HIV are well-accepted in the market and it'll be an advantage for Mangalam Drugs, says Managing Director Govardhan Dhoot.
Mangalam Drugs' has fallen 37 percent since its high in December 8, 2015 and has been in lower circuit for the past 7 sessions.
Mangalam Drugs Organic is into manufacturing APIs for malaria & HIV drugs and is the world's largest manufacturer of anti-malarial APIs.